LAUREN KIRVEN: Open Payments
NPI 1710513270 · FLORENCE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,994 in 88 payments from 23 companies in 2025. Trend: 2023 $299 · 2024 $1,217 · 2025 $1,994
Food & beverage: $1,994
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $330 |
| Janssen Biotech, Inc. | 10 | $189 |
| CVRx, Inc. | 1 | $187 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $183 |
| GENZYME CORPORATION | 5 | $159 |
| Madrigal Pharmaceuticals | 7 | $139 |
| Ferring Pharmaceuticals Inc. | 4 | $137 |
| QOL Medical, LLC | 5 | $94 |
| Regeneron Healthcare Solutions, Inc. | 4 | $89 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $66 |
Products named: DUPIXENT, RINVOQ, Barostim Neo System, TREMFYA, ENTYVIO, REZDIFFRA, REBYOTA, Sucraid.
Industry payments across SC — which companies pay providers there.
